Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Recruiting × Pseudomyxoma Peritonei × Clear all

Phase

Phase 3 2 Phase 2 2 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 21 Neoplasms 20 Breast Neoplasms 20 Glioma 18 Prostatic Neoplasms 15 Pancreatic Neoplasms 15 Recurrence 13 Leukemia, Myeloid, Acute 13 Glioblastoma 13 Solid Tumor 11 Lymphoma, Non-Hodgkin 10 Squamous Cell Carcinoma of Head and Neck 9 Lymphoma 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Hematologic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Triple Negative Breast Neoplasms 7 Polycystic Ovary Syndrome 7 Lymphoma, B-Cell 7 Lung Neoplasms 7 Colorectal Neoplasms 7 Carcinoma, Hepatocellular 7 Head and Neck Neoplasms 6 Melanoma 5 Leukemia 5 Burkitt Lymphoma 5 Brain Neoplasms 5 Stomach Neoplasms 4 Neoplasm Metastasis 4 Myasthenia Gravis 4

Interventions

tislelizumab 1 molgramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡